LFDLE
MRNA icon

La Financiere de L'Echiquier’s Moderna MRNA Stock Holding History

La Financiere de L'Echiquier’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$267K Sell
2,250
-200
-8% -$25.3K 0.01% 99
2024
Q1 		$261K Buy
2,450
+250
+11% +$25.2K 0.01% 100
2023
Q4 		$219K Sell
2,200
-92,047
-98% -$7.74M 0.01% 98
2023
Q3 		$9.73M Buy
94,247
+32,895
+54% +$3.67M 0.5% 45
2023
Q2 		$7.45M Sell
61,352
-13,741
-18% -$1.83M 0.37% 51
2023
Q1 		$11.5M Buy
75,093
+29,445
+65% +$4.86M 0.6% 38
2022
Q4 		$8.2M Sell
45,648
-2,857
-6% -$467K 0.52% 39
2022
Q3 		$5.74M Sell
48,505
-2,772
-5% -$421K 0.36% 53
2022
Q2 		$7.33M Sell
51,277
-6,168
-11% -$882K 0.43% 49
2022
Q1 		$9.9M Buy
57,445
+15,877
+38% +$2.67M 0.41% 51
2021
Q4 		$10.6M Buy
41,568
+37,568
+939% +$11M 0.36% 55
2021
Q3 		$1.54M Buy
+4,000
New +$1.48M 0.05% 81

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

La Financiere de L'Echiquier's MRNA Position: Q2 2024 in Review

La Financiere de L'Echiquier reduced its Moderna (MRNA) stake by 8.2% in Q2 2024, selling an estimated $25.3K and leaving 2,250 shares worth $267K. The position accounts for 0.01% of the portfolio, ranked #99.

La Financiere de L'Echiquier first reported a position in MRNA in Q3 2021 and has held it in 12 quarters since. The position peaked at $11.5M in Q1 2023. 955 funds tracked by Wall St. Rank hold MRNA as of Q2 2024.

  • La Financiere de L'Echiquier held 2,250 shares of Moderna worth $267K as of Q2 2024.
  • La Financiere de L'Echiquier sold 200 Moderna shares in Q2 2024, an estimated $25.3K.
  • Moderna made up 0.01% of La Financiere de L'Echiquier's portfolio in Q2 2024, its #99 holding.
  • La Financiere de L'Echiquier first reported a position in Moderna in Q3 2021 and has held it in 12 quarters since.
  • La Financiere de L'Echiquier's Moderna position peaked at $11.5M in Q1 2023.
  • 955 funds tracked by Wall St. Rank held Moderna as of Q2 2024.

Based on La Financiere de L'Echiquier's 13F filing for Q2 2024, filed 18 Jul 2024.